Altay Therapeutics
PrivateLast Round
Grant
Sep 1, 2023
Est. Valuation
$2.14M
Total Funding Raised
$3.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Altay Therapeutics is a biotechnology company that develops small molecule therapeutics targeting transcription factors to treat chronic inflammatory diseases, neuromuscular disorders, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altay Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Altay Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2023 | ||||
| Grant | Jul 11, 2023 | ||||
| Seed | Sep 21, 2022 | ||||
| Accelerator | Mar 16, 2020 |
Key People
Founding team and executive leadership
Altay Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Solve FSHD | Grant, Seed |
| Y Combinator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 59% MoM.
- Apr 21, 2026
Monthly visitors increased 621% MoM, reaching 1.2K.
Altay Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Altay Therapeutics's valuation, stock price, and market status.